Redaelli Claudio A, Dufour Jean-François, Wagner Markus, Schilling Martin, Hüsler Jürg, Krähenbühl Lukas, Büchler Markus W, Reichen Jürg
Department of Visceral and Transplantation Surgery, University of Bern, Bern, Switzerland.
Ann Surg. 2002 Jan;235(1):77-85. doi: 10.1097/00000658-200201000-00010.
To analyze a single center's 6-year experience with 258 consecutive patients undergoing major hepatic resection for primary or secondary malignancy of the liver, and to examine the predictive value of preoperative liver function assessment.
Despite the substantial improvements in diagnostic and surgical techniques that have made liver surgery a safer procedure, careful patient selection remains mandatory to achieve good results in patients with hepatic tumors.
In this prospective study, 258 patients undergoing hepatic resection were enrolled: 111 for metastases, 78 for hepatocellular carcinoma (HCC), 21 for cholangiocellular carcinoma, and 48 for other primary hepatic tumors. One hundred fifty-eight patients underwent segment-oriented liver resection, including hemihepatectomies, and 100 had subsegmental resections. Thirty-two clinical and biochemical parameters were analyzed, including liver function assessment by the galactose elimination capacity (GEC) test, a measure of hepatic functional reserve, to predict postoperative (60-day) rates of death and complications and long-term survival. All variables were determined within 5 days before surgery. Data were subjected to univariate and multivariate analysis for two patient subgroups (HCC and non-HCC). The cutoffs for GEC in both groups were predefined. Long-term survival (>60 days) was subjected to Kaplan-Meier analysis and the Cox proportional hazard model.
In the entire group of 258 patients, a GEC less than 6 mg/min/kg was the only preoperative biochemical parameter that predicted postoperative complications and death by univariate and stepwise regression analysis. A GEC of more than 6 mg/min/kg was also significantly associated with longer survival. This predictive value could also be shown in the subgroup of 180 patients with tumors other than HCC. In the subgroup of 78 patients with HCC, a GEC less than 4 mg/min/kg predicted postoperative complications and death by univariate and stepwise regression analysis. Further, a GEC of more than 4 mg/min/kg was also associated with longer survival.
This prospective study establishes the preoperative determination of the hepatic reserve by GEC as a strong independent and valuable predictor for short- and long-term outcome in patients with primary and secondary hepatic tumors undergoing resection.
分析单中心连续258例因原发性或继发性肝脏恶性肿瘤接受大肝切除术患者的6年经验,并探讨术前肝功能评估的预测价值。
尽管诊断和手术技术有了显著进步,使肝脏手术更安全,但谨慎选择患者对于肝肿瘤患者取得良好疗效仍然至关重要。
在这项前瞻性研究中,纳入258例行肝切除术的患者:111例为转移性肿瘤,78例为肝细胞癌(HCC),21例为胆管细胞癌,48例为其他原发性肝肿瘤。158例患者接受了以肝段为导向的肝切除术,包括半肝切除术,100例接受了亚肝段切除术。分析了32项临床和生化参数,包括通过半乳糖清除能力(GEC)试验评估肝功能,这是一种肝储备功能的测量方法,以预测术后(60天)的死亡率、并发症发生率和长期生存率。所有变量均在手术前5天内测定。对两个患者亚组(HCC和非HCC)的数据进行单因素和多因素分析。两组的GEC临界值均预先设定。长期生存(>60天)采用Kaplan-Meier分析和Cox比例风险模型。
在258例患者的整个队列中,单因素和逐步回归分析显示,GEC低于6mg/min/kg是唯一能预测术后并发症和死亡的术前生化参数。GEC高于6mg/min/kg也与更长的生存期显著相关。这种预测价值在180例非HCC肿瘤患者的亚组中也得到了证实。在78例HCC患者的亚组中,单因素和逐步回归分析显示,GEC低于4mg/min/kg可预测术后并发症和死亡。此外,GEC高于4mg/min/kg也与更长的生存期相关。
这项前瞻性研究证实,术前通过GEC测定肝储备是接受切除术的原发性和继发性肝肿瘤患者短期和长期预后的强大独立且有价值的预测指标。